ClinicalTrials.gov record
Terminated Phase 4 Interventional

Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)

ClinicalTrials.gov ID: NCT05228184

Public ClinicalTrials.gov record NCT05228184. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 6:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Comparative Study Between Liquid (Tirosint®-SOL) and Tablet Formulations of Levothyroxine in Neonates and Infants With Congenital Hypothyroidism

Study identification

NCT ID
NCT05228184
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
IBSA Institut Biochimique SA
Industry
Enrollment
34 participants

Conditions and interventions

Interventions

  • Levothyroxine Sodium Drug
  • Tirosint®-SOL Drug

Drug

Eligibility (public fields only)

Age range
1 Day to 9 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 20, 2022
Primary completion
Mar 26, 2025
Completion
Mar 26, 2025
Last update posted
Oct 22, 2025

2022 – 2025

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Children's Hospital of Los Angeles Los Angeles California 90027
CHOC Children's Hospital Orange California 92868
University of California San Francisco San Francisco California 94143
Yale University New Haven Connecticut 06511
Children's Hospital of Atlanta Atlanta Georgia 30329
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611
Boston Children's Hospital Boston Massachusetts 02115
Children's Mercy Hospital and Clinics Kansas City Missouri 64111
Children's Hospital Medical Center Cincinnati Ohio 45229
Cook Children's Health Care Systems Fort Worth Texas 76104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05228184, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05228184 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →